Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm (B) and mef (A) in South Korea-Reference-Cited by-同舟云学术

Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm (B) and mef (A) in South Korea

Published:2003-12 Issue:12 Volume:41 Page:5787-5791
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Waites Ken B.¹²,Jones Kellie E.²,Kim Kyung Hyo¹³,Moser Stephen A.¹²,Johnson Crystal N.²,Hollingshead Susan K.²,Kang Eun-Suk⁴,Hong Ki Sook⁴,Benjamin William H.¹²

Affiliation:

1. Departments of Pathology

2. Microbiology, University of Alabama at Birmingham, Birmingham, Alabama

3. Pediatrics

4. Laboratory Medicine, College of Medicine, Ewha Woman's University, Seoul, South Korea

Abstract

ABSTRACT Macrolide resistance was detected in 64 of 77 (83.1%) Streptococcus pneumoniae isolates from South Korea. Seven (10.9%) isolates contained only mef (A), 32 (50%) contained only erm (B), and 25 (39.1%) contained mef (A) and erm (B). Nineteen isolates containing mef (A) and erm (B) belonged to serotype 19F, and seven isolates were identical to the Taiwan 19F -14 clone.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.41.12.5787-5791.2003

Reference16 articles.

1. Chong, Y., K. Lee, O. H. Kwon, and J. Henrichsen. 1995. Capsular types and antimicrobial resistance of Streptococcus pneumoniae isolated in Korea. Eur. J. Clin. Microbiol. Infect. Dis.14:528-531.

2. Mutation in 23S rRNA Responsible for Resistance to 16-Membered Macrolides and Streptogramins in Streptococcus pneumoniae

3. Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 Study

4. Farrell, D. J., I. Morrissey, S. Bakker, and D. Felmingham. 2002. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J. Antimicrob. Chemother.50(Suppl. S1):39-47.

5. Felmingham, D., R. R. Reinert, Y. Hirakata, and A. Rodloff. 2002. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. J. Antimicrob. Chemother.50(Suppl. S1):25-37.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotypic characterization of Streptococcus pneumoniae serotype 19F in Malaysia;Infection, Genetics and Evolution;2014-01

2. Macrolide resistance in Streptococcus pneumoniae isolated from Argentinian pediatric patients suffering from acute otitis media;Revista Argentina de Microbiología;2013-10

3. Molecular Resistance Mechanisms of Macrolide-Resistant Invasive Streptococcus pneumoniae Isolates from Alaska, 1986 to 2010;Antimicrobial Agents and Chemotherapy;2013-08-19

4. Characterization of highly antimicrobial-resistant clinical pneumococcal isolates recovered in a Chinese hospital during 2009–2010;Journal of Medical Microbiology;2012-01-01

5. Risk factors for 30-day mortality in adult patients with pneumococcal bacteraemia, and the impact of antimicrobial resistance on clinical outcomes;Epidemiology and Infection;2011-09-12